No probs 6186, I got burnt bad ( no pun intended)by CCE... Clinical Cell a few years back. The approvals required by PXS and CCE were regulatory, and therefore the outcomes binary in the sense they made or broke the companies. The outcome is not so dramatic with SRX and therefore IMO not binary. If the trial results were nagative, I would be looking at a massive and quick SP decline..I would not be looking to sell but to buy on an over correction on the SP...anything under $18...as this company can continue to be profitable as a second line treatment. Cheers.
No probs 6186, I got burnt bad ( no pun intended)by CCE......
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $74.27M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 17.5¢ | 17.5¢ | $2.587K | 14.78K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 6407725 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 1792238 | 19 |
View Market Depth
| Last trade - 13.11pm 31/07/2024 (20 minute delay) ? |
| SRX (ASX) Chart |